Back to search
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A study to evaluate the safety and preliminary efficacy of iMSC in subjects with SR-aGVHD
The purpose of this study is to assess the efficacy and safety of ruxolitinib therapy in Chinese adults and adolescents (≥ 12 years old) with Grade II-IV steroi…
This is a pilot, prospective, non-profit, multicenter, uncontrolled, open-label study to evaluate the safety and feasibility of FMT in patients aged between 3 m…
The purpose of this registration is to list Managed Access Programs (MAPs) related to INC424, Ruxolitinib
The study was an open-label, single-arm, Phase I/II multi-center study to investigate the PK, activity and safety of ruxolitinib added to the patient's immunosu…